Fund HoldingsNEA Management Company, LLC

Total Portfolio Value
$1.59B
Total Bought
$5.64M
Total Sold
$440.69M
Net Transaction
-$435.06M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
MBX Biosciences, Inc.(MBX)3,614,4863,614,4860107,892199,52012.56%+91,627
Trevi Therapeutics, Inc.(TRVI)13,222,22813,222,2280157,741246,59515.53%+88,853
Monte Rosa Therapeutics, Inc.(GLUE)7,692,2987,692,2980126,538186,15411.72%+59,615
Zenas BioPharma, Inc.(ZBIO)4,023,2194,023,219078,654102,1096.43%+23,455
Savara, Inc.(SVRA)24,471,26424,471,2640133,613150,7439.49%+17,130
Aurinia Pharmaceuticals, Inc.(AUPH)3,969,8343,969,834058,83367,3684.24%+8,535
CRISPR Therapeutics AG(CRSP)1,058,5701,058,570050,35657,7343.64%+7,378
Karyopharm Therapeutics Inc.0576,780+576,78005,6350.35%+5,635
Nkarta, Inc.3,568,7813,568,78107,53010,1000.64%+2,570
Korro Bio, Inc.1,297,8931,297,893014,69217,1061.08%+2,414
X4 Pharmaceuticals, Inc.3,233,7433,233,743013,35515,1020.95%+1,746
Senti Biosciences, Inc.
COM NEW
3,775,6153,775,61503,0664,1530.26%+1,087
Champions Oncology, Inc.1,713,7201,713,72009,85410,5570.66%+703
Marker Therapeutics, Inc.1,625,6781,625,67802,1132,3900.15%+276
OnKure Therapeutics, Inc.478,548478,54801,9812,1820.14%+201
ImageneBio, Inc.50,00550,00502502950.02%+45
Gossamer Bio, Inc.1,000,0001,000,00003291650.01%-164
LeonaBio, Inc.464,398464,39804,7744,2680.27%-506
Phathom Pharmaceuticals, Inc.1,960,1691,960,169021,77721,2681.34%-510
Black Diamond Therapeutics, Inc.4,448,7574,448,75709,4768,2300.52%-1,246
Coursera, Inc.(COUR)12,867,76912,867,769074,89072,5744.57%-2,316
Inventiva SA(IVA)1,462,5861,462,58608,0305,5290.35%-2,501
ORIC Pharmaceuticals, Inc.(ORIC)4,118,6214,118,621052,18344,6052.81%-7,578
CVRx, Inc.2,026,0831,954,440-71,64319,16710,0460.63%-9,121
Spyglass Pharma, Inc.(SGP)7,392,3017,392,3010191,535164,55310.36%-26,982
Celcuity Inc.(CELC)2,285,5611,710,561-575,000260,874178,95911.27%-81,915
Arcellx, Inc.
COMMON STOCK
3,045,2620-3,045,262349,6570-349,657
Page 1 of 1